First FDA-approved CAR T Cell Therapy for Lymphoma to Be Available at City of Hope

October 18, 2017 | City of Hope

City of Hope will be the one of the first authorized centers in the nation to provide axicabtagene ciloleucel, which the U.S. FDA announced today is the first approved CAR T therapy for adult patients for some types of non-Hodgkin lymphoma

Continue Reading

Grad Student Profile: Cai Roberts

July 7, 2017 | Samantha Bonar

Graduate student Cai Roberts is exploring a novel twist on cancer treatment that targets a unique protein. The protein, called Twist, may allow cancer cells to take some devious turns within the body.

City of Hope Grad Student Receives Prestigious Fellowship

April 4, 2017 | Samantha Bonar

Carlos Mendez-Dorantes, a second-year graduate student, was recently awarded a Ford Foundation Predoctoral Fellowship, administered by the National Academies of Sciences, Engineering and Medicine.

Grad Student Breaking New Ground in Glioblastoma

April 4, 2017 | Samantha Bonar

Even though he is still a graduate student, Qi Cui is already doing groundbreaking glioblastoma research at City of Hope.

An Artist Finds His Place in Medicine

January 13, 2017 | Katie Neith

Ford Fellowship gives graduate student Jose Ortiz more confidence in pursuit of his Ph.D.

Graduate student spotlight: Dongrui Wang and cancer immunotherapy

October 17, 2016 | Denise Heady

Graduate student Dongrui Wang’s poster presentation at the 19th annual American Society of Gene & Cell Therapy was selected as the conference’s Outstanding Poster Presentation for his research initiatives in gene and cell therapy. Here Wang talks about what motivated him to pursue a career in science, what keeps him inspired and the innovative research he is working on at City of Hope.